Ardelyx Inc

NASDAQ:ARDX   3:59:51 PM EDT
7.42
+0.04 (+0.47%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)731.90M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$1.94 Million
Adjusted EPS-$0.37
See more estimates
10-Day MA$7.18
50-Day MA$7.38
200-Day MA$6.56
See more pivots

Ardelyx Inc Stock, NASDAQ:ARDX

34175 Ardenwood Boulevard, Suite 200, Fremont, California 94555
United States of America
Phone: +1.510.745.1700
Number of Employees: 129

Description

Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet on October 17, 2007 and is headquartered in Fremont, CA.